University Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.
Department of Internal Medicine, Academic Teaching Hospital Hall in Tirol, Milserstrasse 10, A-6060 Hall in Tirol, Austria.
Int J Cardiol. 2021 Apr 1;328:191-196. doi: 10.1016/j.ijcard.2020.12.006. Epub 2020 Dec 9.
The inflammatory response due to myocardial tissue injury in the setting of acute ST-elevation myocardial infarction (STEMI) is essential for proper local infarct healing. However, an excessive inflammatory response may aggravate myocardial damage and hampers infarct healing processes. The present study aimed to investigate the association of systemic inflammatory biomarkers with infarct size (IS) dynamics post-STEMI, using cardiac magnetic resonance (CMR) imaging.
This prospective observational study included 245 STEMI patients treated with primary percutaneous coronary intervention (pPCI). Peak values of high-sensitivity C-reactive protein (hs-CRP), white blood cell count (WBCc) and fibrinogen were determined serially until 96 h after pPCI. Infarct healing, defined as relative IS reduction from baseline to 4 months after STEMI, was assessed using late gadolinium enhanced CMR imaging.
IS significantly decreased from 16% of left ventricular mass (LVM) (Interquartile range [IQR]:8-24) at baseline to 10% (IQR:5-17) at 4 months (p < 0.001). Relative IS reduction was 35% (IQR:8-50). Whereas peak WBCc (p = 0.926) and peak fibrinogen (p = 0.161) were not significantly associated with relative IS reduction, peak hs-CRP showed a significant association with IS reduction (p = 0.003). In multivariable logistic regression analysis, the association between peak hs-CRP and relative IS reduction remained significant after adjustment for baseline IS, hypertension, hs-cardiac troponin T and N-terminal pro B-type natriuretic peptide (odds ratio:0.35 [95% confidence interval:0.19-0.63]; p = 0.001).
In STEMI patients treated with pPCI, hs-CRP was independently associated with 4 months IS reduction as determined by CMR, suggesting a pathophysiological interplay between inflammation and adverse infarct healing in survivors of acute STEMI.
急性 ST 段抬高型心肌梗死(STEMI)时心肌组织损伤引起的炎症反应对于局部梗死愈合至关重要。然而,过度的炎症反应可能会加重心肌损伤,并阻碍梗死愈合过程。本研究旨在使用心脏磁共振(CMR)成像研究全身性炎症生物标志物与 STEMI 后梗死面积(IS)动态变化的关系。
这项前瞻性观察性研究纳入了 245 例接受直接经皮冠状动脉介入治疗(pPCI)的 STEMI 患者。连续测定高敏 C 反应蛋白(hs-CRP)、白细胞计数(WBCc)和纤维蛋白原的峰值水平,直至 pPCI 后 96 小时。使用钆延迟增强 CMR 成像评估梗死后愈合情况,定义为 STEMI 后 4 个月时与基线相比相对 IS 减少。
IS 从基线时左心室质量(LVM)的 16%(四分位距[IQR]:8-24)显著下降至 4 个月时的 10%(IQR:5-17)(p<0.001)。相对 IS 减少为 35%(IQR:8-50)。尽管峰值 WBCc(p=0.926)和峰值纤维蛋白原(p=0.161)与相对 IS 减少无显著相关性,但峰值 hs-CRP 与 IS 减少呈显著相关性(p=0.003)。在多变量逻辑回归分析中,在校正基线 IS、高血压、hs 心肌肌钙蛋白 T 和 N 末端 pro B 型利钠肽后,峰值 hs-CRP 与相对 IS 减少之间的相关性仍然显著(比值比:0.35[95%置信区间:0.19-0.63];p=0.001)。
在接受 pPCI 治疗的 STEMI 患者中,hs-CRP 与 CMR 确定的 4 个月 IS 减少独立相关,提示急性 STEMI 幸存者中炎症与不良梗死愈合之间存在病理生理相互作用。